The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 2485 -2491
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803023

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, K. X.
Right arrow Articles by Denhardt, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, K. X.
Right arrow Articles by Denhardt, D. T.

Plasma Osteopontin Modulates Chronic Restraint Stress-Induced Thymus Atrophy by Regulating Stress Hormones: Inhibition by an Anti-Osteopontin Monoclonal Antibody1

Kathryn X. Wang*, Yufang F. Shi{ddagger}, Yacov Ron{ddagger}, Christian C. Kazanecki* and David T. Denhardt2,*,{dagger}

* Graduate Program in Cell and Developmental Biology and {dagger} Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Nelson Biological Laboratories, Piscataway, NJ 08854; and {ddagger} Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08854

Osteopontin (OPN) is a cytokine implicated in mediating responses to certain stressors, including mechanical, oxidative, and cellular stress. However, the involvement of OPN in responding to other physical and psychological stress is largely unexplored. Our previous research revealed that OPN is critical for hind limb-unloading induced lymphoid organ atrophy through modulation of corticosteroid production. In this study, we demonstrate that OPN–/– mice are resistant to chronic restraint stress (CRS)-induced lymphoid (largely thymus) organ atrophy; additionally, the stress-induced up-regulation of corticosterone production is significantly reduced in OPN–/– mice. Underlying this observation is the fact that normal adrenocorticotropic hormone levels are substantially reduced in the OPN–/– mice. Our data demonstrate both that injection of OPN into OPN-deficient mice enhances the CRS-induced lymphoid organ atrophy and that injection of a specific anti-OPN mAb (2C5) into wild-type mice ameliorates the CRS-induced organ atrophy; changes in corticosterone levels were also partially reversed. These studies reveal that circulating OPN plays a significant role in the regulation of the hypothalamus-pituitary-adrenal axis hormones and that it augments CRS-induced organ atrophy.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This research was supported in part by Busch Biomedical Research Grant 749164 (to D.T.D.), National Multiple Sclerosis Society Grant 3699A10 (to D.T.D.), Georgetta Harrar (to D.T.D.), and National Space Biomedical Research Institute Grant IIH00405 (to Y.F.S.).

2 Address correspondence and reprint requests to Dr. David T. Denhardt, Rutgers, The State University of New Jersey, Nelson Biological Laboratories, 604 Allison Road, Piscataway, NJ 08854.

3 Abbreviations used in this paper: OPN, osteopontin; CORT, corticosterone; CRS, chronic restraint stress; HPA, hypothalamus-pituitary-adrenal; HU, hind limb unloading; ACTH, adrenocorticotropic hormone; Wt, wild type.




This article has been cited by other articles:


Home page
J EndocrinolHome page
A. L Gruver, M. S Ventevogel, and G. D Sempowski
Leptin receptor is expressed in thymus medulla and leptin protects against thymic remodeling during endotoxemia-induced thymus involution
J. Endocrinol., October 1, 2009; 203(1): 75 - 85.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.